Proton-activated chloride channel 1 is essential for innate host defense against bacterial sepsis
Abstract
Bacterial sepsis remains a devastating clinical problem. Here, we describe a protective role for the recently discovered acid-sensitive, proton-activated chloride channel, PACC1 (PAC/ASOR/TMEM206), during sepsis. Initially, we found PACC1 was enriched in healthy human and mouse mononuclear phagocytes, particularly macrophages, and differentially regulated by inflammatory stimuli, suggesting PACC1 involvement in innate immunity. To further investigate, we generated de novo Pacc1 knockout ( −/− ) mice, which presented without major immunologic abnormalities at baseline. Compared to wild-type (WT), Pacc1 −/− myeloid cells showed normal phagocytic uptake of acid-insensitive Escherichia coli BioParticles , but impaired development of the acidifying phagolysosome using acid-sensitive E. coli BioParticles. Transcriptomic profiling of Pacc1 −/− macrophages revealed dysregulated phagolysosomal and cytokine networks (e.g., interferons). Because phagolysosomal bacterial clearance is essential to resolve infection, we challenged Pacc1 −/− mice with intraperitoneal gram-negative E. coli sepsis. Pacc1 −/− mice displayed increased bacterial burden, immune cell infiltration, inflammation, and lethality. In contrast, phagocytosis-independent E. coli lipopolysaccharide (LPS)-induced endotoxemia yielded comparable WT and Pacc1 −/− survival, as well as similar inflammatory responses. Finally, we engineered Pacc1 -floxed ( fl/fl ) mice crossed with a myeloid lineage Cre-deleter strain to interrogate myeloid cell–intrinsic PACC1 in vivo. Consistent with a predominate role for PACC1 during phagocytosis and bacterial clearance in these cells, LysM-Cre/Pacc1 fl/fl mice exhibited impaired E. coli sepsis survival but indifferent endotoxemia phenotypes. In conclusion, PACC1 links sterilizing phagolysosomal activity with immune networks in sepsis pathobiology.
Article Details
Journal Info
Proceedings of the National Academy of Sciences
National Academy of Sciences
Authors (11)
Lucien P. Garo
Pulmonary Center, Department of Medicine, Boston University Chobanian and Avedisian School of Medicine
Kevin Brueck
Pulmonary Center, Department of Medicine, Boston University Chobanian and Avedisian School of Medicine
Sarah Walachowski
Pulmonary Center, Department of Medicine, Boston University Chobanian and Avedisian School of Medicine
Archana Jayaraman
Pulmonary Center, Department of Medicine, Boston University Chobanian and Avedisian School of Medicine
Marcel Strueve
Center for Thrombosis and Hemostasis, University Medical Center of the Johannes Gutenberg-University Mainz
Shuang Xu
Hulbert Yang
Pulmonary Center, Department of Medicine, Boston University Chobanian and Avedisian School of Medicine
Matthew Helmkamp
Pulmonary Center, Department of Medicine, Boston University Chobanian and Avedisian School of Medicine
Seung Hoan Choi
Broad Institute, Cambridge, MA, USA.
Christoph Reinhardt
Center for Thrombosis and Hemostasis, University Medical Center of the Johannes Gutenberg-University Mainz
Markus Bosmann
Pulmonary Center, Department of Medicine, Boston University Chobanian and Avedisian School of Medicine